Review of guidelines for prevention of Creutzfeldt–Jakob disease transmission in medical settings in EU Member States and Norway
Since 1996, following outbreaks of variant Creutzfeldt–Jakob disease (vCJD) in several Member States, both the European Union and individual countries have implemented special public health measures and renewed research efforts in the field of human and animal transmissible spongiform encephalopathies (TSEs).
The purpose of this report is to provide a review of available national documents aimed at controlling the transmission of human TSE in medical settings, taking the epidemiological situation and recent research results into account. The ultimate goal was to identify potential needs and tools useful to Member States for drawing up recommendations suited to their specific needs.
Guidance on community engagement for public health events caused by communicable disease threats in the EU/EEA
13 Feb 2020 - This guidance on community engagement for public health emergency preparedness is intended for public health authorities in EU/EEA Member States. It is meant to provide step-by-step technical support to Member States who are initiating or professionalising their core community engagement capacity. The guidance is organised according to the three core stages of the preparedness cycle: anticipation, response, and recovery.
Infection prevention and control for the care of patients with 2019-nCoV in healthcare settings
2 Feb 2020 - This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control measures during the management of suspected and confirmed cases of 2019-nCoV infection.
HIV and men who have sex with men - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
10 Jan 2020 - This report is part of the 2018 progress reports monitoring the implementation of the Dublin Declaration. It presents the situation among men who have sex with men (MSM), a key group affected by HIV in the WHO European Region, and outlines priorities for action.